12874
W.-M. Dai, H. Li / Tetrahedron 63 (2007) 12866–12876
4.4.1. N-Cyclohexyl-2-[N0-cyclohexyl-(40-methoxycar-
bonyl-20-nitrophenyl)amino]-2-phenylacetamid (9a) and
N-cyclohexyl-2-hydroxy-2-phenylacetamide (12). Com-
pounds 9a and 12 were prepared in 77% and 10% yields, re-
spectively (Table 2, entry 1). Compound 9a: a yellow oil;
Rf¼0.30 (33% EtOAc in hexane); IR (film) 3361, 2933,
(M+Na+, 100); HRMS (+ESI) calcd for C26H33N3O6Na+
(M+Na+), 505.2262; found: 506.2241.
4.4.4. N-Benzyl-2-[N0-benzyl-(40-methoxycarbonyl-20-
nitrophenyl)amino]-2-(400-methoxyphenyl)acetamide
(9d). Prepared in 51% yield (Table 2, entry 4). Compound
9d: a yellow crystalline solid; mp 153–155 ꢁC (EtOAc–
hexane); Rf¼0.50 (33% EtOAc in hexane); IR (film)
3363, 3312, 1724, 1667, 1612, 1530, 1512, 1251 cmꢀ1; 1H
NMR (400 MHz, CDCl3) d 8.16 (d, J¼1.6 Hz, 1H), 7.88
(dd, J¼8.4, 1.6 Hz, 1H), 7.37 (br d, J¼9.2 Hz, 2H), 7.30
(t, J¼6.0 Hz, 1H, –NH), 7.20–7.08 (m, 6H), 6.99 (d,
J¼8.4 Hz, 1H), 6.93–6.87 (m, 4H), 6.69 (br d, J¼6.8 Hz,
2H), 4.94 (s, 1H), 4.42 and 4.11 (ABqd, J¼14.4,
7.2 Hz, 2H), 4.09 (s, 2H), 3.93 (s, 3H), 3.81 (s, 3H); 13C
2855, 1731, 1673, 1532, 1290, 1249 cmꢀ1 1H NMR
;
(400 MHz, CDCl3) d 8.31 (d, J¼2.0 Hz, 1H), 7.94 (dd, J¼
8.4, 1.6 Hz, 1H), 7.66 (d, J¼8.8 Hz, 1H), 7.47 (d, J¼
6.8 Hz, 2H), 7.23–7.17 (m, 4H), 5.01 (s, 1H), 3.90 (s, 3H),
3.56–3.53 (m, 1H), 2.85 (t, J¼11.6 Hz, 1H), 1.87–0.73 (m,
20H); 13C NMR (100 MHz, CDCl3) d 170.2, 164.6, 149.3,
143.6, 136.9, 132.1, 131.5, 128.7 (ꢂ2), 128.2 (ꢂ2), 127.9,
126.7, 125.7, 71.6, 62.9, 52.6, 47.6, 32.5, 32.3, 29.3, 29.2,
25.8, 25.8, 25.3 (ꢂ2), 24.6 (ꢂ2); HRMS (+ESI) calcd for
C28H35N3O5Na+ (M+Na+), 516.2469; found: 516.2465.
NMR (100 MHz, CDCl3)
d
169.9, 164.7, 159.9,
146.2, 145.6, 137.6, 134.3, 133.1, 129.9 (ꢂ2), 129.0
(ꢂ2), 128.4, (ꢂ2), 128.3 (ꢂ2), 127.8, 127.6 (ꢂ2), 127.2,
127.2, 126.3, 126.2, 125.9, 114.3 (ꢂ2), 70.1, 56.2, 55.3,
52.5, 43.3; MS (+ESI) m/z (relative intensity) 562
(M+Na+, 100), 540 (M+H+, 24). Anal. Calcd for
C31H29N3O6: C, 69.00; H, 5.42; N, 7.79. Found: C, 69.03;
H, 5.41; N, 7.79.
Compound 12: a colorless oil; Rf¼0.30 (20% EtOAc in hex-
ane); IR (KBr) 3342, 3264, 2934, 2853, 1642, 1060 cmꢀ1
;
1H NMR (400 MHz, CDCl3) d 7.37–7.32 (m, 5H), 6.00 (d,
J¼6.4 Hz, 1H), 4.96 (d, J¼3.2 Hz, 1H), 3.75–3.73 (m,
2H), 1.84 (t, J¼12.4 Hz, 2H), 1.75–1.51 (m, 3H), 1.04–
1.03 (m, 2H), 1.03–1.00 (m, 3H); 13C NMR (100 MHz,
CDCl3) d 171.1, 139.7, 128.8 (ꢂ2), 128.5, 126.8 (ꢂ2),
74.0, 48.4, 32.9, 32.8, 25.4, 24.7, 24.6; HRMS (+ESI) calcd
for C14H19NO2Na+ (M+Na+), 256.1308; found: 256.1305.
4.4.5. N-Benzyl-2-[N0-benzyl-(20-methoxycarbonyl-40-
nitrophenyl)amino]-2-phenylacetamide (9e). Prepared in
43% yield (Table 2, entry 5). Compound 9e: a yellow crys-
talline solid; mp 146–148 ꢁC (EtOAc–hexane); Rf¼0.60
(33% EtOAc in hexane); IR (film) 3308, 1721, 1667, 1521,
4.4.2. N-Benzyl-2-[N0-benzyl-(40-methoxycarbonyl-20-
nitrophenyl)amino]-2-phenylacetamide (9b). Prepared in
66% yield (Table 2, entry 2). Compound 9b: a yellow crys-
talline solid; mp 117–119 ꢁC (EtOAc–hexane); Rf¼0.60
(33% EtOAc in hexane); IR (film) 3363, 1727, 1673, 1531,
1
1339, 1266 cmꢀ1; H NMR (400 MHz, CDCl3) d 8.33 (d,
J¼2.4 Hz, 1H), 8.02 (dd, J¼8.8, 2.4 Hz, 1H), 8.03–7.98
(br s, 1H, –NH), 7.47–7.44 (m, 2H), 7.39–7.30 (m, 3H),
7.20–7.09 (m, 6H), 7.00 (d, J¼9.2 Hz, 1H), 6.95 (dd,
J¼8.0, 1.2 Hz, 2H), 6.68 (d, J¼7.2 Hz, 2H), 5.03 (s, 1H),
4.47 and 4.09 (ABqd, J¼14.4, 6.8 Hz, 2H), 416 and 4.06
(ABq, J¼14.4 Hz, 2H), 3.86 (s, 3H); 13C NMR (100 MHz,
CDCl3) d 169.9, 166.4, 155.0, 142.8, 137.9, 135.6, 134.8,
128.9 (ꢂ2), 128.8 (ꢂ2), 128.8 (ꢂ2), 128.6, 128.3 (ꢂ4),
127.9 (ꢂ2), 127.7, 127.4, 127.2, 126.8, 126.5, 125.0, 71.8,
57.5, 52.8, 43.3; MS (+ESI) m/z (relative intensity) 548
(M+K+, 100), 532 (M+Na+, 73), 510 (M+H+, 15). Anal.
Calcd for C30H27N3O5: C, 70.71; H, 5.34; N, 8.25. Found:
C, 70.74; H, 5.33; N, 8.25.
1
1291 cmꢀ1; H NMR (400 MHz, CDCl3) d 8.16 (d, J¼
2.0 Hz, 1H), 7.88 (dd, J¼8.4, 1.6 Hz, 1H), 7.48 (d,
J¼6.4 Hz, 2H), 7.38–7.34 (m, 4H), 7.20–7.07 (m, 6H),
7.01 (d, J¼8.8 Hz, 1H), 6.89–6.87 (m, 2H), 6.69 (d, J¼
7.2 Hz, 2H), 5.00 (s, 1H), 4.41 and 4.07 (ABqd, J¼14.4,
7.2 Hz, 2H), 4.09 (s, 2H), 3.93 (s, 3H); 13C NMR
(100 MHz, CDCl3) d 169.6, 164.6, 146.1, 145.6, 137.5,
135.3, 134.1, 133.2, 129.0 (ꢂ2), 128.9 (ꢂ2), 128.7, 128.6
(ꢂ2), 128.4 (ꢂ2), 128.3 (ꢂ2), 127.9, 127.6 (ꢂ2), 127.1,
126.3, 126.2, 125.8, 70.7, 56.3, 52.5, 43.2; HRMS (+ESI)
calcd for C30H27N3O5Na+ (M+Na+), 532.1843; found:
532.1817.
4.4.6. N-Benzyl-2-[N0-benzyl-(50-methoxycarbonyl-20-
nitrophenyl)amino]-2-phenylacetamide (9f). Prepared in
45% yield (Table 2, entry 6). Compound 9f: an orange crys-
talline solid; mp 137–139 ꢁC (EtOAc–hexane); Rf¼0.58
(33% EtOAc in hexane); IR (film) 3368, 1729, 1667, 1529,
The structure of 9b was confirmed by X-ray crystallographic
analysis. The structural drawing is found in Figure 2.18
4.4.3. N-Cyclohexyl-2-[N0-cyclohexyl-(40-methoxycar-
bonyl-20-nitrophenyl)amino]-2-(furan-200-yl)acetamide
(9c). Prepared in 64% yield at room temperature for 72 h in
dark (Table 2, entry 3). Compound 9c: a yellow oil; Rf¼0.30
(33% EtOAc in hexane); IR (film) 3364, 2933, 2855, 1731,
1282 cmꢀ1 1H NMR (400 MHz, CDCl3) d 7.75 (dd,
;
J¼8.4, 1.6 Hz, 1H), 7.68 (d, J¼1.2 Hz, 1H), 7.54–7.50 (m,
3H), 7.46 (d, J¼8.8 Hz, 1H), 7.40–7.32 (m, 3H), 7.21–
7.080 (m, 6H), 6.92 (dd, J¼7.6, 1.6 Hz, 2H), 6.67 (d,
J¼7.2 Hz, 2H), 5.00 (s, 1H), 4.43 and 4.14 (ABqd,
J¼14.4, 6.8 Hz, 2H), 4.06 and 4.00 (ABq, J¼13.6 Hz,
2H), 3.89 (s, 3H); 13C NMR (100 MHz, CDCl3) d 169.8,
164.7, 149.8, 142.0, 137.7, 135.7, 134.1, 133.5, 129.4
(ꢂ2), 128.9 (ꢂ2), 128.7 (ꢂ2), 128.6, 128.4 (ꢂ2), 128.3
(ꢂ2), 128.1, 127.9, 127.6 (ꢂ2), 127.2, 126.5, 124.3, 71.5,
57.5, 52.7, 43.2; MS (+ESI) m/z (relative intensity) 548
(M+K+, 100), 532 (M+Na+, 80), 510 (M+H+, 22). Anal.
Calcd for C30H27N3O5: C, 70.71; H, 5.34; N, 8.25. Found:
C, 70.74; H, 5.34; N, 8.25.
1682, 1537, 1289, 1250 cmꢀ1
;
1H NMR (400 MHz,
CDCl3) d 8.25 (d, J¼2.0 Hz, 1H), 7.98 (dd, J¼8.4, 1.6 Hz,
1H), 7.68–7.66 (br s, 1H, –NH), 7.28 (d, J¼8.8 Hz, 1H),
7.21 (br s, 1H), 6.33 (d, J¼2.8 Hz, 1H), 6.16 (d, J¼2.0 Hz,
1H), 5.08 (s, 1H), 3.89 (s, 3H), 3.75–3.60 (m, 1H), 2.78 (t,
J¼12.0 Hz, 1H), 1.90–0.75 (m, 20H); 13C NMR
(100 MHz, CDCl3) d 168.3, 164.6, 149.2, 149.1, 144.0,
142.4, 132.2, 130.7, 127.8, 125.5, 110.7, 110.6, 64.1, 63.7,
52.5, 48.0, 32.5, 32.5, 30.6, 29.0, 26.0, 25.7, 25.3, 25.2,
24.7 (ꢂ2); MS (+ESI) m/z (relative intensity) 506